Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) has granted a total of 47,013 stock options, exercisable at $0.71 per share and valid for a term of three years, and a total of 514,801 restricted share units, valid for a term of between one and three years, to consultants and employees of the company and its subsidiaries. The stock options and restricted share units are issued pursuant to the Company’s stock compensation plans and are subject to a statutory hold period of four months and one day from issuance, in addition to vesting provisions.
In addition, and further to the Company’s press release dated July 18, 2025, the Company has retained the marketing services of 45 Degrees, Inc. (“45 degrees“) and Investment Publishing LLC (“Publish investment”) to provide digital marketing and investor awareness services until September 30, 2026. No additional compensation will be paid to 45 Degrees of Investment Publishing for the additional services provided.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians around the world.
In addition to the GLM, there is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Our proprietary technology software and systems have helped more than 350 physicians deliver care to more than 750,000 patient visits and enable physicians to independently launch and manage their own virtual or hybrid practices – improving efficiency, restoring physician autonomy and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful doctor-patient interactions. We strive to reach underserved, rural and remote communities in Canada that often lack access to primary care physicians and to support patients with Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable, and patient-centric.
For more information about Rocket Doctor AI Inc products and services, please contact:
http://www.rocketdoctor.ai or email: [email protected]
FOR ADDITIONAL INFORMATION PLEASE CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
[email protected]
For media inquiries please contact: [email protected]
Call: +1 (778) 819 8321
Cautionary Statements
This press release contains forward-looking statements regarding the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will,” “may,” “should,” “anticipate,” “expect” and similar expressions. All statements, other than statements of historical fact, included in this press release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include other risks described from time to time in Rocket Doctor AI Inc.’s filings. to securities regulators.
The reader is cautioned that assumptions used in preparing forward-looking information may prove to be incorrect. Events or circumstances could cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond Rocket Doctor AI Inc.’s control. The reader is cautioned not to place undue reliance on any forward-looking information. Although this information was considered reasonable by management at the time of preparation, it may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements in this press release are expressly qualified by this cautionary statement. The forward-looking statements in this press release are made as of the date of this press release and Rocket Doctor AI Inc. will only publicly update or revise the included forward-looking statements as expressly required by Canadian securities legislation.
